Organotin implications in anticarcinogenesis. Background and thymus involvement.
A comprehensive study of the scientific literature regarding tin content in normal and pathogenic human tissue has disclosed that various organotin materials retard both the onset and growth of cancer in laboratory animals, and decreased tissue tin in humans may be associated with tumour development. Initial studies by the authors have shown that the thymus gland of the mouse possesses a relatively high concentration of tin and is also the major site of accumulation for 14C-labelled tri-n-butyltin fluoride (TBTF). When mammary cancer-prone mice with transplanted tumours were orally dosed continuously with this agent in their drinking water, the tumour growth rate was significantly reduced. Both mouse mammary tumours and human lung tumours show low tin content compared to normal body tissue.
D000818:Animals; D006801:Humans; D008175:Lung Neoplasms / Q000032:analysis; D051379:Mice; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000032:analysis*; D009947:Organotin Compounds / Q000032:analysis*; D013950:Thymus Gland / Q000032:analysis*; D014001:Tin / Q000502:physiology*; D014018:Tissue Distribution
D009947:Organotin Compounds; D014001:Tin